Ahmedabad, Oct 10 (UNI) In order to consolidate it position in dermatology and focus in dentistry, Wockhardt Limited has forged an in-licensing agreement with the UK-based Sinclair Pharma plc to market a range of dermatology and dental products.
As per the 10-year agreement, signed in September 2008, covering a range of patented and innovative products like Papulex, Atopiclair, Alocair and Decapinol range, Wockhardt will leverage its technological capabilities by manufacturing the formulations in India from bulk imported from Sinclair Pharma, a Wockhardt release said today.
''As a part of our India business strategy, in-licensing is seen as one of our key growth drivers. These in-licensing deals will fulfil our aim of getting niche global products for the benefit of our Indian patients. We bring to India break through products that have proved their effectiveness in Europe and USA and also strengthen our existing portfolios,'' Wockhardt chairman Habil Khorakiwala said.
Wockhardt is also in talks with Sinclair on contract manufacturing of the signed products for their European markets and to bring in to India the next phase of dermatology products from the Sinclair stable.
UNI PVN RN SKB1337